All things Paediatric

Join the fourth ENT day to learn from past controversies in ENT and how to manage patients who present diagnose or treatment challenges. These meetings offer the perfect opportunity for networking with colleagues and renowned speakers. Lunch is included when booking the morning and afternoon meetings.

Morning meeting

In the morning session some of the more common Paediatric ENT problems seen by all Otolaryngologists will be looked at, starting with the questions we hear from parents all the time. Haytham Kubba from Glasgow will cover glue ear, Su De and Sunil Sharma from Liverpool will look at recurrent acute otitis media, Steven Powell from Newcastle at how to deal with a blocked nose once the adenoids have been removed and Kate Blackmore from Middlesborough on how to approach a lump in the neck.

We will then have an address from Prof Julina Ongkasuwan from the Childrens Hospital in Texas who is one of a very small band of Paediatric Otolaryngologists who also have a fellowship in laryngology alongside a Paediatric ENT fellowship.  

Following coffee there will be the continuation of the Update series looking at Paediatric Otolaryngology. There will be input from Vicky Thorpe and Alex Stewart from the specialist speech and language therapy team at Great Ormond Street hospital and also Reema Nandi, one of the senior Paediatric Anaesthetists at Great Ormond Street Hospital, who will then present her approach to anaesthesia for Paediatric ENT. Jason Powell from the University of Newcastle will consider the question often heard is ‘What are tonsils and adenoids for and can we do without them’ Over the years there have been mixed messages coming out from various NHS and ENT statutory bodies and both clinicians and parents are confused.  Ravi Thevasagayasm from Sheffield Childrens Hospital will conclude with a talk on Inducible Laryngeal Obstruction in Children.

Afternoon meeting

In the afternoon session, we will explore advanced investigations and treatments for children with inner and middle ear diseases, featuring experts from across the UK. Jessica Bewick and Konstance Tzifa will discuss their work in creating a dedicated paediatric hearing loss MDT, including evolving genetic investigations and the impact of Cytomegalovirus on acquired sensorineural hearing loss. Isobel Fitzgerald O’Connor will share her experiences in delivering outreach services and surgical ear care in resource-limited settings, highlighting the challenges and the need for tailored local solutions. Tamsin Brown will then present her development of a low-cost hearing device, "HearGlueEar," for children with conductive hearing loss. 

After the break, our third Otology Masterclass will focus on managing childhood cholesteatoma and will cover training requirements, decision-making, and the latest techniques for complete removal, hearing rehabilitation, and long-term reconstruction.  The session will conclude with a talk by Michel Poulain, a demographic scientist who will discuss the story behind his identification of 5 "Blue Zones" around the world where the longest-lived populations reside.  He will then share his insights into achieving an exceptionally long and healthy life. 

By attending this event, you will learn:

• The minimum requirements for a paediatric hearing loss MDT
• The difficulties supporting resource-limited regions of the world and what we can do to help
• State-of-the-art childhood cholesteatoma management
• Insight into exceptional health and lifespan and what we can gain personally by adopting a “Blue Zone” philosophy

Follow us on:

Facebook
Instagram
LinkedIn
Twitter
YouTube

The Laryngology, Rhinology and Otology Sections would like to thank our Annual Sponsors B.Braun Medical Ltd, DP Medical Systems LTD, Medtronic and Soluvos Medical for their valued support of the 2024 to 2025 Academic Programme. We would also like to thank our sponsors Carleton Medical Ltd, KARL STORZ Endoscopy (UK) Ltd, Minim Healthcare Ltd, Oticon Medical, Smith & Nephew and Stryker for supporting this meeting.
Please note that none of the companies listed has had any influence or involvement over the agenda, content or organisation of this meeting.